Recurrent SARS-CoV-2 RNA Detection after COVID-19 Illness Onset during Pregnancy

Emerg Infect Dis. 2022 Apr;28(4):873-876. doi: 10.3201/eid2804.212354. Epub 2022 Feb 25.

Abstract

The Surveillance for Emerging Threats to Mothers and Babies Network conducts longitudinal surveillance of pregnant persons in the United States with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection during pregnancy. Of 6,551 infected pregnant persons in this analysis, 142 (2.2%) had positive RNA tests >90 days and up to 416 days after infection.

Keywords: 2019 Novel Coronavirus Disease; COVID-19; RT-PCR; SARS-CoV-2; United States; coronavirus disease; pregnancy; real-time reverse transcription PCR; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

MeSH terms

  • COVID-19* / diagnosis
  • Female
  • Humans
  • Laboratories
  • Pregnancy
  • Pregnancy Complications, Infectious* / epidemiology
  • RNA, Viral
  • SARS-CoV-2 / genetics
  • Serologic Tests
  • United States

Substances

  • RNA, Viral